Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grants (2018R1A6A3A11047049 and 2022R1A2C1091832) funded by the Korean government (MSIT).
References
- Andrabi, S.A., Dawson, T.M., and Dawson, V.L. (2008). Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann. N. Y. Acad. Sci. 1147, 233-241. https://doi.org/10.1196/annals.1427.014
- Berger, J.M. and Moon, Y.A. (2021). Increased hepatic lipogenesis elevates liver cholesterol content. Mol. Cells 44, 116-125. https://doi.org/10.14348/molcells.2021.2147
- Begriche, K., Massart, J., Robin, M.A., Bonnet, F., and Fromenty, B. (2013). Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 58, 1497-1507. https://doi.org/10.1002/hep.26226
- Berardo, C., Di Pasqua, L.G., Cagna, M., Richelmi, P., Vairetti, M., and Ferrigno, A. (2020). Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research. Int. J. Mol. Sci. 21, 9646.
- Bitterman, K.J., Anderson, R.M., Cohen, H.Y., Latorre-Esteves, M., and Sinclair, D.A. (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099-45107. https://doi.org/10.1074/jbc.M205670200
- Brenner, C., Galluzzi, L., Kepp, O., and Kroemer, G. (2013). Decoding cell death signals in liver inflammation. J. Hepatol. 59, 583-594. https://doi.org/10.1016/j.jhep.2013.03.033
- Camacho-Pereira, J., Tarrago, M.G., Chini, C.C.S., Nin, V., Escande, C., Warner, G.M., Puranik, A S., Schoon, R.A., Reid, J.M., Galina, A., et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127-1139. https://doi.org/10.1016/j.cmet.2016.05.006
- Canto, C., Houtkooper, R.H., Pirinen, E., Youn, D.Y., Oosterveer, M.H., Cen, Y., Fernandez-Marcos, P.J., Yamamoto, H., Andreux, P.A., Cettour-Rose, P., et al. (2012). The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab.15, 838-847. https://doi.org/10.1016/j.cmet.2012.04.022
- Cazanave, S.C. and Gores, G.J. (2010). Mechanisms and clinical implications of hepatocyte lipoapoptosis. Clin. Lipidol. 5, 71-85. https://doi.org/10.2217/clp.09.85
- Choi, Y., Abdelmegeed, M.A., and Song, B.J. (2017). Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: role of disturbed lipid homeostasis and increased oxidative stress. Food Chem. Toxicol. 103, 111-121. https://doi.org/10.1016/j.fct.2017.02.039
- Choi, Y.J., Shin, H.S., Choi, H.S., Park, J.W., Jo, I., Oh, E.S., Lee, K.Y., Lee, B.H., Johnson, R.J., and Kang, D. H. (2014). Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab. Invest. 94, 1114-1125. https://doi.org/10.1038/labinvest.2014.98
- Covarrubias, A.J., Perrone, R., Grozio, A., and Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 22, 119-141. https://doi.org/10.1038/s41580-020-00313-x
- Dall, M., Penke, M., Sulek, K., Matz-Soja, M., Holst, B., Garten, A., Kiess, W., and Treebak, J.T. (2018). Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice. Mol. Cell Endocrinol. 473, 245-256. https://doi.org/10.1016/j.mce.2018.01.025
- DeBerardinis, R.J. and Chandel, N.S. (2016). Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200.
- de Oliveira, G.C., Kanamori, K.S., Auxiliadora-Martins, M., Chini, C.C.S., and Chini, E.N. (2018). Measuring CD38 hydrolase and cyclase activities: 1,N6-Ethenonicotinamide Adenine Dinucleotide (ε-NAD) and Nicotinamide Guanine Dinucleotide (NGD) fluorescence-based methods. Bio Protoc. 8, e2938.
- Federico, A., Rosato, V., Masarone, M., Torre, P., Dallio, M., Romeo, M., and Persico, M. (2021). The role of fructose in non-alcoholic steatohepatitis: old relationship and new insights. Nutrients 13, 1314.
- Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R.A., Bugianesi, E., and Gastaldelli, A. (2013). Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5, 1544-1560. https://doi.org/10.3390/nu5051544
- Gariani, K., Menzies, K.J., Ryu, D., Wegner, C.J., Wang, X., Ropelle, E.R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. (2016). Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 63, 1190-1204. https://doi.org/10.1002/hep.28245
- Gariani, K., Ryu, D., Menzies, K.J., Yi, H.S., Stein, S., Zhang, H., Perino, A., Lemos, V., Katsyuba, E., Jha, P., et al. (2017). Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. J. Hepatol. 66, 132-141. https://doi.org/10.1016/j.jhep.2016.08.024
- Geidl-Flueck, B. and Gerber, P.A. (2017). Insights into the hexose liver metabolism-glucose versus fructose. Nutrients 9, 1026.
- Geng, Y., Faber, K.N., de Meijer, V.E., Blokzijl, H., and Moshage, H. (2021). How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol. Int. 15, 21-35. https://doi.org/10.1007/s12072-020-10121-2
- Guarino, M. and Dufour, J.F. (2019). Nicotinamide and NAFLD: is there nothing new under the sun? Metabolites 9, 180.
- Haffar, T., Berube-Simard, F., and Bousette, N. (2015). Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes. Biochem. Biophys. Res. Commun. 468, 73-78. https://doi.org/10.1016/j.bbrc.2015.10.162
- Houtkooper, R.H., Pirinen, E., and Auwerx, J. (2012). Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225-238. https://doi.org/10.1038/nrm3293
- Hu, H., Tian, M., Ding, C., and Yu, S. (2019). The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front. Immunol. 9, 3083.
- Hui, H., Huang, D., McArthur, D., Nissen, N., Boros, L.G., and Heaney, A.P. (2009). Direct spectrophotometric determination of serum fructose in pancreatic cancer patients. Pancreas 38, 706-712. https://doi.org/10.1097/MPA.0b013e3181a7c6e5
- Imai, S. and Guarente, L. (2010). Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol. Sci. 31, 212-220. https://doi.org/10.1016/j.tips.2010.02.003
- Ishimoto, T., Lanaspa, M.A., Rivard, C.J., Roncal-Jimenez, C.A., Orlicky, D.J., Cicerchi, C., McMahan, R.H., Abdelmalek, M.F., Rosen, H.R., Jackman, M.R., et al. (2013). High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 58, 1632-1643. https://doi.org/10.1002/hep.26594
- Iurlaro, R. and Munoz-Pinedo, C. (2016). Cell death induced by endoplasmic reticulum stress. FEBS J. 283, 2640-2652. https://doi.org/10.1111/febs.13598
- Jensen, T., Abdelmalek, M.F., Sullivan, S., Nadeau, K.J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.H., et al. (2018). Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J. Hepatol. 68, 1063-1075. https://doi.org/10.1016/j.jhep.2018.01.019
- Kanda, T., Matsuoka, S., Yamazaki, M., Shibata, T., Nirei, K., Takahashi, H., Kaneko, T., Fujisawa, M., Higuchi, T., Nakamura, H., et al. (2018). Apoptosis and non-alcoholic fatty liver diseases. World J. Gastroenterol. 24, 2661-2672. https://doi.org/10.3748/wjg.v24.i25.2661
- Katsyuba, E., Mottis, A., Zietak, M., De Franco, F., van der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., et al. (2018). De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature 563, 354-359. https://doi.org/10.1038/s41586-018-0645-6
- Klimova, N. and Kristian, T. (2019). Multi-targeted effect of nicotinamide mononucleotide on brain bioenergetic metabolism. Neurochem. Res. 44, 2280-2287. https://doi.org/10.1007/s11064-019-02729-0
- Koves, T.R., Ussher, J.R., Noland, R.C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J.R., Newgard, C. B., et al. (2008). Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45-56. https://doi.org/10.1016/j.cmet.2007.10.013
- Koyama, Y. and Brenner, D.A. (2017). Liver inflammation and fibrosis. J. Clin. Invest. 127, 55-64. https://doi.org/10.1172/JCI88881
- Krenkel, O., Puengel, T., Govaere, O., Abdallah, A.T., Mossanen, J.C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., et al. (2018). Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67, 1270-1283. https://doi.org/10.1002/hep.29544
- Lanaspa, M.A., Sanchez-Lozada, L.G., Choi, Y.J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C.A., Ishimoto, T., Li, N., Marek, G., Duranay, M., et al. (2012). Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J. Biol. Chem. 287, 40732-40744. https://doi.org/10.1074/jbc.M112.399899
- Lipke, K., Kubis-Kubiak, A., and Piwowar, A. (2022). Molecular Mechanism of lipotoxicity as an interesting aspect in the development of pathological states-current view of knowledge. Cells 11, 844.
- Ly, L.D., Ly, D.D., Nguyen, N.T., Kim, J.H., Yoo, H., Chung, J., Lee, M.S., Cha, S.K., and Park, K.S. (2020). Mitochondrial Ca2+ uptake relieves palmitate-induced cytosolic Ca2+ overload in MIN6 cells. Mol. Cells 43, 66-75.
- Marra, F. and Svegliati-Baroni, G. (2018). Lipotoxicity and the gut-liver axis in NASH pathogenesis. J. Hepatol. 68, 280-295. https://doi.org/10.1016/j.jhep.2017.11.014
- Martin-Guerrero, S.M., Casado, P., Hijazi, M., Rajeeve, V., Plaza-Diaz, J., Abadia-Molina, F., Navascues, J., Cuadros, M.A., Cutillas, P.R., and MartinOliva, D. (2020). PARP-1 activation after oxidative insult promotes energy stress-dependent phosphorylation of YAP1 and reduces cell viability. Biochem. J. 477, 4491-4513. https://doi.org/10.1042/BCJ20200525
- Mouchiroud, L., Houtkooper, R.H., and Auwerx, J. (2013). NAD+ metabolism: a therapeutic target for age-related metabolic disease. Crit. Rev. Biochem. Mol. Biol. 48, 397-408. https://doi.org/10.3109/10409238.2013.789479
- Mukhopadhyay, P., Horvath, B., Rajesh, M., Varga, Z.V., Gariani, K., Ryu, D., Cao, Z., Holovac, E., Park, O., Zhou, Z., et al. (2017). PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J. Hepatol. 66, 589-600. https://doi.org/10.1016/j.jhep.2016.10.023
- Nassir, F. and Ibdah, J.A. (2016). Sirtuins and nonalcoholic fatty liver disease. World J. Gastroenterol. 22, 10084-10092. https://doi.org/10.3748/wjg.v22.i46.10084
- Nassir, F., Rector, R.S., Hammoud, G.M., and Ibdah, J.A. (2015). Pathogenesis and prevention of hepatic steatosis. Gastroenterol. Hepatol. 11, 167-175.
- Pardo, V., Gonzalez-Rodriguez, A., Muntane, J., Kozma, S.C., and Valverde, A.M. (2015). Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection. Food Chem. Toxicol. 80, 298-309. https://doi.org/10.1016/j.fct.2015.03.029
- Parthasarathy, G., Revelo, X., and Malhi, H. (2020). Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol. Commun. 4, 478-492. https://doi.org/10.1002/hep4.1479
- Peng, C., Stewart, A.G., Woodman, O.L., Ritchie, R.H., and Qin, C.X. (2020). Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments. Front. Pharmacol. 11, 603926.
- Penke, M., Larsen, P.S., Schuster, S., Dall, M., Jensen, B.A., Gorski, T., Meusel, A., Richter, S., Vienberg, S.G., Treebak, J.T., et al. (2015). Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet. Mol. Cell. Endocrinol. 412, 65-72. https://doi.org/10.1016/j.mce.2015.05.028
- Pham, T.X., Bae, M., Kim, M.B., Lee, Y., Hu, S., Kang, H., Park, Y.K., and Lee, J.Y. (2019). Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2451-2463. https://doi.org/10.1016/j.bbadis.2019.06.009
- Pimenta, A.S., Gaidhu, M.P., Habib, S., So, M., Fediuc, S., Mirpourian, M., Musheev, M., Curi, R., and Ceddia, R.B. (2008). Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells. J. Cell. Physiol. 217, 478-485. https://doi.org/10.1002/jcp.21520
- Rada, P., Gonzalez-Rodriguez, A., Garcia-Monzon, C., and Valverde, A.M. (2020). Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 11, 802.
- Ramanathan, R., Ali, A.H., and Ibdah, J.A. (2022). Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease. Int. J. Mol. Sci. 23, 7280.
- Roeb, E. and Weiskirchen, R. (2021). Fructose and non-alcoholic steatohepatitis. Front. Pharmacol. 12, 634344.
- Salech, F., Ponce, D.P., Paula-Lima, A.C., SanMartin, C.D., and Behrens, M.I. (2020). Nicotinamide, a Poly [ADP-Ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer's disease. Front. Aging Neurosci. 12, 255.
- Softic, S., Cohen, D.E., and Kahn, C.R. (2016). Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig. Dis. Sci. 61, 1282-1293. https://doi.org/10.1007/s10620-016-4054-0
- Softic, S., Meyer, J.G., Wang, G.X., Gupta, M.K., Batista, T.M., Lauritzen, H.P.M.M., Fujisaka, S., Serra, D., Herrero, L., Willoughby, J., et al. (2019). Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab. 30, 735-753.e4. https://doi.org/10.1016/j.cmet.2019.09.003
- Softic, S., Gupta, M.K., Wang, G.X., Fujisaka, S., O'Neill, B.T., Rao, T.N., Willoughby, J., Harbison, C., Fitzgerald, K., Ilkayeva, O., et al. (2017). Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J. Clin. Invest. 127, 4059-4074. https://doi.org/10.1172/JCI94585
- Spahis, S., Delvin, E., Borys, J.M., and Levy, E. (2017). Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid. Redox Signal. 26, 519-541. https://doi.org/10.1089/ars.2016.6776
- Sugimoto, K., Hosotani, T., Kawasaki, T., Nakagawa, K., Hayashi, S., Nakano, Y., Inui, H., and Yamanouchi, T. (2010). Eucalyptus leaf extract suppresses the postprandial elevation of portal, cardiac and peripheral fructose concentrations after sucrose ingestion in rats. J. Clin. Biochem. Nutr. 46, 205-211. https://doi.org/10.3164/jcbn.09-93
- Sunny, N.E., Bril, F., and Cusi, K. (2017). Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies. Trends Endocrinol. Metab. 28, 250-260. https://doi.org/10.1016/j.tem.2016.11.006
- Wang, D.X., Qing, S.L., Miao, Z.W., Luo, H.Y., Tian, J.S., Zhang, X.P., Wang, S.N., Zhang, T.G., and Miao, C.Y. (2023). Hepatic nampt deficiency aggravates dyslipidemia and fatty liver in high fat diet fed mice. Cells 12, 568.
- Xie, L., Wen, K., Li, Q., Huang, C.C., Zhao, J.L., Zhao, Q.H., Xiao, Y.F., Guan, X.H., Qian, Y.S., Gan, L., et al. (2021). CD38 deficiency protects mice from high fat diet-induced nonalcoholic fatty liver disease through activating NAD+/Sirtuins signaling pathways-mediated inhibition of lipid accumulation and oxidative stress in hepatocytes. Int. J. Biol. Sci. 17, 4305-4315. https://doi.org/10.7150/ijbs.65588
- Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P.E., Zhou, X., Li, C., Shen, G., and Zou, B. (2020). NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 5, 227.
- Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X.X., Pandey, S.K., Bhanot, S., Monia, B.P., Li, Y.X., and Diehl, A.M. (2007). Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366-1374. https://doi.org/10.1002/hep.21655
- Yoshino, J., Mills, K.F., Yoon, M.J., and Imai, S. (2011). Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528-536. https://doi.org/10.1016/j.cmet.2011.08.014
- Zhang, D.M., Jiao, R.Q., and Kong, L.D. (2017). High dietary fructose: direct or indirect dangerous factors disturbing tissue and organ functions. Nutrients, 9, 335.
- Zhou, Y., Wang, Q., Mark Evers, B., and Chung, D.H. (2006). Oxidative stress-induced intestinal epithelial cell apoptosis is mediated by p38 MAPK. Biochem. Biophys. Res. Commun. 350, 860-865. https://doi.org/10.1016/j.bbrc.2006.09.103
- Zeng, C. and Chen, M. (2022). Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis. Biomolecules 12, 1079.